175 related articles for article (PubMed ID: 23084584)
1. Human epididymis protein 4 is up-regulated in gastric and pancreatic adenocarcinomas.
O'Neal RL; Nam KT; LaFleur BJ; Barlow B; Nozaki K; Lee HJ; Kim WH; Yang HK; Shi C; Maitra A; Montgomery E; Washington MK; El Rifai W; Drapkin RI; Goldenring JR
Hum Pathol; 2013 May; 44(5):734-42. PubMed ID: 23084584
[TBL] [Abstract][Full Text] [Related]
2. Mucin 16 (cancer antigen 125) expression in human tissues and cell lines and correlation with clinical outcome in adenocarcinomas of the pancreas, esophagus, stomach, and colon.
Streppel MM; Vincent A; Mukherjee R; Campbell NR; Chen SH; Konstantopoulos K; Goggins MG; Van Seuningen I; Maitra A; Montgomery EA
Hum Pathol; 2012 Oct; 43(10):1755-63. PubMed ID: 22542127
[TBL] [Abstract][Full Text] [Related]
3. Anterior gradient 2 profiling in Barrett columnar epithelia and adenocarcinoma.
Pizzi M; Fassan M; Realdon S; Balistreri M; Battaglia G; Giacometti C; Zaninotto G; Zagonel V; De Boni M; Rugge M
Hum Pathol; 2012 Nov; 43(11):1839-44. PubMed ID: 22521076
[TBL] [Abstract][Full Text] [Related]
4. Cytokeratin expression patterns in noncardia, intestinal metaplasia-associated gastric adenocarcinoma: implication for the evaluation of intestinal metaplasia and tumors at the esophagogastric junction.
Shen B; Ormsby AH; Shen C; Dumot JA; Shao YW; Bevins CL; Gramlich TL
Cancer; 2002 Feb; 94(3):820-31. PubMed ID: 11857318
[TBL] [Abstract][Full Text] [Related]
5. Proteomic profiling of paraffin-embedded samples identifies metaplasia-specific and early-stage gastric cancer biomarkers.
Sousa JF; Ham AJ; Whitwell C; Nam KT; Lee HJ; Yang HK; Kim WH; Zhang B; Li M; LaFleur B; Liebler DC; Goldenring JR
Am J Pathol; 2012 Nov; 181(5):1560-72. PubMed ID: 22944598
[TBL] [Abstract][Full Text] [Related]
6. Expression profile of malignant and nonmalignant lesions of esophagus and stomach: differential activity of functional modules related to inflammation and lipid metabolism.
Gomes LI; Esteves GH; Carvalho AF; Cristo EB; Hirata R; Martins WK; Marques SM; Camargo LP; Brentani H; Pelosof A; Zitron C; Sallum RA; Montagnini A; Soares FA; Neves EJ; Reis LF
Cancer Res; 2005 Aug; 65(16):7127-36. PubMed ID: 16103062
[TBL] [Abstract][Full Text] [Related]
7. Human epididymis protein 4 immunostaining of malignant ascites differentiates cancer of Müllerian origin from gastrointestinal cancer.
Stiekema A; Van de Vijver KK; Boot H; Broeks A; Korse CM; van Driel WJ; Kenter GG; Lok CA
Cancer Cytopathol; 2017 Mar; 125(3):197-204. PubMed ID: 28199067
[TBL] [Abstract][Full Text] [Related]
8. Early HER2 dysregulation in gastric and oesophageal carcinogenesis.
Fassan M; Mastracci L; Grillo F; Zagonel V; Bruno S; Battaglia G; Pitto F; Nitti D; Celiento T; Zaninotto G; Fiocca R; Rugge M
Histopathology; 2012 Nov; 61(5):769-76. PubMed ID: 22882541
[TBL] [Abstract][Full Text] [Related]
9. High levels of human epididymis protein 4 mRNA and protein expression are associated with chemoresistance and a poor prognosis in pancreatic cancer.
Ohkuma R; Yada E; Ishikawa S; Komura D; Kubota Y; Hamada K; Horiike A; Ishiguro T; Hirasawa Y; Ariizumi H; Shida M; Watanabe M; Onoue R; Ando K; Tsurutani J; Yoshimura K; Sasada T; Aoki T; Murakami M; Norose T; Ohike N; Takimoto M; Kobayashi S; Tsunoda T; Wada S
Int J Oncol; 2021 Jan; 58(1):57-69. PubMed ID: 33367933
[TBL] [Abstract][Full Text] [Related]
10. Concordant loss of MTAP and p16/CDKN2A expression in gastroesophageal carcinogenesis: evidence of homozygous deletion in esophageal noninvasive precursor lesions and therapeutic implications.
Powell EL; Leoni LM; Canto MI; Forastiere AA; Iocobuzio-Donahue CA; Wang JS; Maitra A; Montgomery E
Am J Surg Pathol; 2005 Nov; 29(11):1497-504. PubMed ID: 16224217
[TBL] [Abstract][Full Text] [Related]
11. Early miR-223 Upregulation in Gastroesophageal Carcinogenesis.
Fassan M; Saraggi D; Balsamo L; Realdon S; Scarpa M; Castoro C; Coati I; Salmaso R; Farinati F; Guzzardo V; Arcidiacono D; Munari G; Gasparini P; Veronese N; Luchini C; Valeri N; Rugge M
Am J Clin Pathol; 2017 Mar; 147(3):301-308. PubMed ID: 28395057
[TBL] [Abstract][Full Text] [Related]
12. Frequent loss of TIMP-3 expression in progression of esophageal and gastric adenocarcinomas.
Gu P; Xing X; Tänzer M; Röcken C; Weichert W; Ivanauskas A; Pross M; Peitz U; Malfertheiner P; Schmid RM; Ebert MP
Neoplasia; 2008 Jun; 10(6):563-72. PubMed ID: 18516293
[TBL] [Abstract][Full Text] [Related]
13. Polymeric immunoglobulin receptor-negative tumors represent a more aggressive type of adenocarcinomas of distal esophagus and gastroesophageal junction.
Gologan A; Acquafondata M; Dhir R; Sepulveda AR
Arch Pathol Lab Med; 2008 Aug; 132(8):1295-301. PubMed ID: 18684029
[TBL] [Abstract][Full Text] [Related]
14. miR-30-HNF4γ and miR-194-NR2F2 regulatory networks contribute to the upregulation of metaplasia markers in the stomach.
Sousa JF; Nam KT; Petersen CP; Lee HJ; Yang HK; Kim WH; Goldenring JR
Gut; 2016 Jun; 65(6):914-24. PubMed ID: 25800782
[TBL] [Abstract][Full Text] [Related]
15. Intestinal metaplasia is the probable common precursor of adenocarcinoma in barrett esophagus and adenocarcinoma of the gastric cardia.
Ruol A; Parenti A; Zaninotto G; Merigliano S; Costantini M; Cagol M; Alfieri R; Bonavina L; Peracchia A; Ancona E
Cancer; 2000 Jun; 88(11):2520-8. PubMed ID: 10861428
[TBL] [Abstract][Full Text] [Related]
16. Ectopic expression of guanylyl cyclase C in adenocarcinomas of the esophagus and stomach.
Park J; Schulz S; Haaf J; Kairys JC; Waldman SA
Cancer Epidemiol Biomarkers Prev; 2002 Aug; 11(8):739-44. PubMed ID: 12163327
[TBL] [Abstract][Full Text] [Related]
17. Establishment of novel in vitro mouse chief cell and SPEM cultures identifies MAL2 as a marker of metaplasia in the stomach.
Weis VG; Petersen CP; Mills JC; Tuma PL; Whitehead RH; Goldenring JR
Am J Physiol Gastrointest Liver Physiol; 2014 Oct; 307(8):G777-92. PubMed ID: 25190476
[TBL] [Abstract][Full Text] [Related]
18. Toll-like receptors 1, 2, 4 and 6 in esophageal epithelium, Barrett's esophagus, dysplasia and adenocarcinoma.
Huhta H; Helminen O; Lehenkari PP; Saarnio J; Karttunen TJ; Kauppila JH
Oncotarget; 2016 Apr; 7(17):23658-67. PubMed ID: 27008696
[TBL] [Abstract][Full Text] [Related]
19. Expression and diagnostic value of HE4 in pancreatic adenocarcinoma.
Huang T; Jiang SW; Qin L; Senkowski C; Lyle C; Terry K; Brower S; Chen H; Glasgow W; Wei Y; Li J
Int J Mol Sci; 2015 Jan; 16(2):2956-70. PubMed ID: 25642754
[TBL] [Abstract][Full Text] [Related]
20. CpG island hypermethylation in progression of esophageal and gastric cancer.
Sato F; Meltzer SJ
Cancer; 2006 Feb; 106(3):483-93. PubMed ID: 16362978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]